CAR-T Funding is Reaching Staggering New Heights
February 23, 2021
A survey reveals nearly US$100 market capitalisation 23 February 2021 A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below. At first the trend was subtle, but the tide has swelled as CAR-T therapies like...
Read More
Applications Closed – Intellectual Property Analyst (Fixed Term)
February 11, 2021
https://www.seek.com.au/job/51507379 Please visit Seek.com for more information and to apply.
Read More
From waging war with elusive pathogens to tackling cancer
September 7, 2020
Cartherics’ newest recruit, Phil Arandjelovic loves it all By Leigh Dayton In his application for Cartherics’ Research Scientist position, Phil noted: “I am an independent and hard-working research scientist who is proficient at working both individually and with a team”. True. What Phil failed to mention is that he loves...
Read More
The answer to self-discovery is found at Cartherics
September 2, 2020
For new recruit Walid Azar, it was about finding his calling. As Walid Azar settles into his new dual role as Senior Research Fellow and Deputy Lab Manager at Cartherics, he feels content that he has finally found his calling. With previous experience in both cancer research and industry, he...
Read More
‘Chance favours the prepared mind’
August 27, 2020
Frederico Calhabeu has followed Louis Pasteur’s advice from France to Cartherics By Leigh Dayton When considering whether to continue his translational research program at the Australian Regenerative Medicine Institute (ARMI), Frederico Calhabeu had a quick chat with Silvio Tiziani, Director, External Strategy and Planning at ARMI. Silvio suggested a quiet...
Read More
Applications Closed : Deputy Lab Manager position
June 30, 2020
Deputy Lab Manager Position Description Cartherics is a new, privately owned biotechnology company, focused on developing cutting edge technologies to empower the immune system to specifically target and eradicate cancer. The focus technology is the ground-breaking technology: Chimeric Antigen Receptor T cells (CAR-T), which have a profound ability to seek...
Read More
Applications Closed : Research Scientist
June 29, 2020
Research Scientist Vacancy Position description Cartherics is a new, privately owned biotechnology company, focused on developing cutting edge technologies to empower the immune system to specifically target and eradicate cancer. The focus technology is the ground-breaking technology: Chimeric Antigen Receptor T cells (CAR-T), which have a profound ability to seek...
Read More
Vacancy filled : Project Manager
February 26, 2020
Background Cartherics Pty Ltd is a private company based in Melbourne, Australia, developing novel, cell-based therapies for the treatment of cancer. Cartherics offices and laboratories are presently located at the Monash Health Translation Precinct (MHTP) located on the Monash Medical Centre campus. The Company has been in operation since the...
Read More
Vacancy filled: Science Writer – Human CAR-T / CAR-NK anti-cancer immunotherapy
November 11, 2019
Position Description Cartherics is seeking a talented, appropriately educated (eg Post-Doctoral Fellow, Post-Graduate, Research Assistant or equivalent) with outstanding writing skills and a solid knowledge base in biomedical science and research. This preferably includes one or more of immunology and immunotherapy, stem cells, cancer biology, gene editing and molecular biology...
Read More
Vacancy filled: Intellectual Property Manager
February 5, 2019
Position Description Cartherics Pty Ltd cartherics.com is a private, early-stage, cellular immunotherapy company, with a core focus on the development of CAR-T cell therapies for the treatment of cancer. It aims to be a world leader in the development of “off-the-shelf” CAR-T cell products. It employs ~15 full-time scientists, complemented...
Read More